Lepu Medical(SZ:300003) Huan Qiu Wang·2026-01-14 05:25Group 1 - The core point of the article is the announcement of the sixth batch of high-value medical consumables procurement results, marking a significant step in China's centralized procurement efforts for medical supplies [1][4] - A total of 12 types of medical consumables, including drug-coated balloons and urological intervention products, were included in this large-scale procurement, with 227 companies participating and 202 companies successfully winning bids for 440 products [1][2] - The procurement process featured a competitive atmosphere, with a unique "revival mechanism" allowing companies that did not win in the first round to lower their prices and re-enter the bidding, promoting a balance between profit preservation and market capture [1][4] Group 2 - In terms of product categories, the drug-coated balloon segment saw a concentrated competition with 32 companies bidding for 42 products, all of which were selected, ensuring a high match with clinical needs while reducing costs for the public [2] - The urological intervention category was more competitive, with 195 companies bidding for 454 products, resulting in 170 companies winning bids for 398 products, including high-end products with special functions [2] - Price reductions varied, with some products seeing significant drops, such as a 85% decrease for a specific product, while leading companies like Lepu Medical maintained reasonable profit margins despite overall price reductions of 52% to 65% for coronary balloon products [4]